{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:34:59Z","timestamp":1786980899375,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK34989"],"award-info":[{"award-number":["DK34989"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s10620-016-4178-2","type":"journal-article","created":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T06:43:15Z","timestamp":1463726595000},"page":"2477-2487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"61","author":[{"given":"Violeta B.","family":"Popov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Ciarleglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Laine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"4178_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","volume":"378","author":"BA Swinburn","year":"2011","unstructured":"Swinburn BA, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804\u2013814.","journal-title":"Lancet"},{"key":"4178_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.7326\/0003-4819-138-1-200301070-00008","volume":"138","author":"A Peeters","year":"2003","unstructured":"Peeters A, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24\u201332.","journal-title":"Ann Intern Med"},{"key":"4178_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","volume":"142","author":"K Cusi","year":"2012","unstructured":"Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012;142:711\u2013725. e6.","journal-title":"Gastroenterology"},{"key":"4178_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ajg.2012.128","volume":"107","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107:811\u2013826.","journal-title":"Am J Gastroenterol"},{"key":"4178_CR5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221\u20131231.","journal-title":"N Engl J Med"},{"key":"4178_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113\u2013121.","journal-title":"Gastroenterology"},{"key":"4178_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MOT.0b013e3283615d30","volume":"18","author":"M Charlton","year":"2013","unstructured":"Charlton M. Evolving aspects of liver transplantation for nonalcoholic steatohepatitis. Curr Opin Organ Transplant. 2013;18:251\u2013258.","journal-title":"Curr Opin Organ Transplant"},{"key":"4178_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.23276","volume":"51","author":"K Promrat","year":"2010","unstructured":"Promrat K, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51:121\u2013129.","journal-title":"Hepatology"},{"key":"4178_CR9","first-page":"CD003619","volume":"6","author":"L Peng","year":"2011","unstructured":"Peng L, Wang J, Li F. Weight reduction for non-alcoholic fatty liver disease. Cochrane Database Syst Rev. 2011;6:CD003619.","journal-title":"Cochrane Database Syst Rev"},{"key":"4178_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","volume":"57","author":"SE Keating","year":"2012","unstructured":"Keating SE, et al. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;57:157\u2013166.","journal-title":"J Hepatol"},{"key":"4178_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","volume":"56","author":"C Thoma","year":"2012","unstructured":"Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012;56:255\u2013266.","journal-title":"J Hepatol"},{"key":"4178_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.gie.2011.08.053","volume":"74","author":"GG Ginsberg","year":"2011","unstructured":"ASGE\/ASMBS Task Force on Endoscopic Bariatric Therapy, Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943\u2013953.","journal-title":"Gastrointest Endosc"},{"key":"4178_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1756283X11398737","volume":"4","author":"BK Abu Dayyeh","year":"2011","unstructured":"Abu Dayyeh BK, Thompson CC. Obesity and bariatrics for the endoscopist: new techniques. Therap Adv Gastroenterol. 2011;4:433\u2013442.","journal-title":"Therap Adv Gastroenterol"},{"key":"4178_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11695-007-9331-8","volume":"18","author":"I Imaz","year":"2008","unstructured":"Imaz I, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841\u2013846.","journal-title":"Obes Surg"},{"key":"4178_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.gie.2012.05.023","volume":"76","author":"YM Lee","year":"2012","unstructured":"Lee YM, et al. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. Gastrointest Endosc. 2012;76:756\u2013760.","journal-title":"Gastrointest Endosc"},{"key":"4178_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53:810\u2013820.","journal-title":"Hepatology"},{"key":"4178_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00592-013-0516-4","volume":"51","author":"L Folini","year":"2014","unstructured":"Folini L, et al. Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding. Acta Diabetol. 2014;51:361\u2013368.","journal-title":"Acta Diabetol"},{"key":"4178_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.gie.2009.06.036","volume":"71","author":"R Forlano","year":"2010","unstructured":"Forlano R, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc. 2010;71:927\u2013933.","journal-title":"Gastrointest Endosc"},{"key":"4178_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","volume":"137","author":"D Prati","year":"2002","unstructured":"Prati D, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1\u201310.","journal-title":"Ann Intern Med"},{"key":"4178_CR20","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s11695-008-9593-9","volume":"18","author":"JM Dumonceau","year":"2008","unstructured":"Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611\u20131617.","journal-title":"Obes Surg"},{"key":"4178_CR21","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1111\/j.1572-0241.1999.01451.x","volume":"94","author":"S Daniel","year":"1999","unstructured":"Daniel S, et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol. 1999;94:3010\u20133014.","journal-title":"Am J Gastroenterol"},{"key":"4178_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/00365529950172880","volume":"34","author":"UL Mathiesen","year":"1999","unstructured":"Mathiesen UL, et al. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol. 1999;34:85\u201391.","journal-title":"Scand J Gastroenterol"},{"key":"4178_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF03347199","volume":"28","author":"G Marchesini","year":"2005","unstructured":"Marchesini G, et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 2005;28:333\u2013339.","journal-title":"J Endocrinol Invest"},{"key":"4178_CR24","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2337\/dc06-1758","volume":"30","author":"TM Wallace","year":"2007","unstructured":"Wallace TM, et al. Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat. Diabetes Care. 2007;30:2673\u20132678.","journal-title":"Diabetes Care"},{"key":"4178_CR25","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1007\/s10620-014-3214-3","volume":"59","author":"Z Chen","year":"2014","unstructured":"Chen Z, Han CK, Pan LL, et al. Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects. Dig Dis Sci. 2014;59:2470\u20132476.","journal-title":"Dig Dis Sci"},{"key":"4178_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-2005-861411","volume":"37","author":"C Thamer","year":"2005","unstructured":"Thamer C, et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res. 2005;37:246\u2013251.","journal-title":"Horm Metab Res"},{"key":"4178_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2005.06.018","volume":"44","author":"A Lonardo","year":"2006","unstructured":"Lonardo A, et al. Hepatic steatosis and insulin resistance: Does etiology make a difference? J Hepatol. 2006;44:190\u2013196.","journal-title":"J Hepatol"},{"key":"4178_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/01.ATV.0000251993.20372.40","volume":"27","author":"DS Lee","year":"2007","unstructured":"Lee DS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:127\u2013133.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4178_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.atherosclerosis.2005.11.036","volume":"189","author":"J Yamada","year":"2006","unstructured":"Yamada J, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006;189:198\u2013205.","journal-title":"Atherosclerosis"},{"key":"4178_CR30","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1381\/096089206778663805","volume":"16","author":"JB Dixon","year":"2006","unstructured":"Dixon JB, Bhathal PS, O\u2019Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16:1278\u20131286.","journal-title":"Obes Surg"},{"key":"4178_CR31","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005\u20132023.","journal-title":"Hepatology"},{"key":"4178_CR32","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.soard.2014.12.006","volume":"11","author":"J Ponce","year":"2015","unstructured":"Ponce J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11:874\u2013881.","journal-title":"Surg Obes Relat Dis"},{"key":"4178_CR33","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s11695-010-0101-7","volume":"21","author":"M Nikolic","year":"2011","unstructured":"Nikolic M, et al. Obesity treatment using a Bioenterics intragastric balloon (BIB)\u2013preliminary Croatian results. Obes Surg. 2011;21:1305\u20131310.","journal-title":"Obes Surg"},{"key":"4178_CR34","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"Diabetes Prevention Program Research, G.","year":"2009","unstructured":"Diabetes Prevention Program Research, G. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677\u20131686.","journal-title":"Lancet"},{"key":"4178_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamasurg.2013.3654","volume":"149","author":"SH Chang","year":"2014","unstructured":"Chang SH, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149:275\u2013287.","journal-title":"JAMA Surg"},{"key":"4178_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.soard.2007.10.004","volume":"4","author":"BA Coakley","year":"2008","unstructured":"Coakley BA, et al. Revisional bariatric surgery for failed restrictive procedures. Surg Obes Relat Dis. 2008;4:581\u2013586.","journal-title":"Surg Obes Relat Dis"},{"key":"4178_CR37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sjostrom","year":"2007","unstructured":"Sjostrom L, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741\u2013752.","journal-title":"N Engl J Med"},{"key":"4178_CR38","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","volume":"137","author":"P Mathurin","year":"2009","unstructured":"Mathurin P, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137:532\u2013540.","journal-title":"Gastroenterology"},{"key":"4178_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.14218\/JCTH.2015.00019","volume":"3","author":"VB Popov","year":"2015","unstructured":"Popov VB, Lim JK. Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss. J Clin Transl Hepatol. 2015;3:230\u2013238.","journal-title":"J Clin Transl Hepatol"},{"key":"4178_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.soard.2009.07.003","volume":"6","author":"M Martin","year":"2010","unstructured":"Martin M, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6:8\u201315.","journal-title":"Surg Obes Relat Dis"},{"key":"4178_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.gie.2010.10.024","volume":"73","author":"M Ryou","year":"2011","unstructured":"Ryou M, et al. Smart Self-Assembling MagnetS for ENdoscopy (SAMSEN) for transoral endoscopic creation of immediate gastrojejunostomy (with video). Gastrointest Endosc. 2011;73:353\u2013359.","journal-title":"Gastrointest Endosc"},{"key":"4178_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1053\/j.gastro.2013.04.002","volume":"145","author":"CC Thompson","year":"2013","unstructured":"Thompson CC, et al. Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery. Gastroenterology. 2013;145:129\u2013137. e3.","journal-title":"Gastroenterology"},{"key":"4178_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.giec.2011.02.004","volume":"21","author":"M Ryou","year":"2011","unstructured":"Ryou M, Ryan MB, Thompson CC. Current status of endoluminal bariatric procedures for primary and revision indications. Gastrointest Endosc Clin N Am. 2011;21:315\u2013333.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"4178_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344\u2013353.","journal-title":"Hepatology"},{"key":"4178_CR45","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.cgh.2013.07.029","volume":"11","author":"C de Jonge","year":"2013","unstructured":"de Jonge C, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013;11:1517\u20131520.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4178_CR46","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.orcp.2013.07.002","volume":"8","author":"M Takihata","year":"2014","unstructured":"Takihata M, et al. Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients. Obes Res Clin Pract. 2014;8:e331\u2013e338.","journal-title":"Obes Res Clin Pract"},{"key":"4178_CR47","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1007\/s11695-013-1027-7","volume":"23","author":"CM Tai","year":"2013","unstructured":"Tai CM, et al. Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal. Obes Surg. 2013;23:2068\u20132074.","journal-title":"Obes Surg"},{"key":"4178_CR48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s11695-011-0571-2","volume":"22","author":"C Zerrweck","year":"2012","unstructured":"Zerrweck C, et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes Surg. 2012;22:777\u2013782.","journal-title":"Obes Surg"},{"key":"4178_CR49","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2169\/internalmedicine.50.5672","volume":"50","author":"Y Sekino","year":"2011","unstructured":"Sekino Y, et al. Time-course of changes of visceral fat area, liver volume and liver fat area during intragastric balloon therapy in Japanese super-obese patients. Intern Med. 2011;50:2449\u20132455.","journal-title":"Intern Med"},{"key":"4178_CR50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11695-010-0310-0","volume":"21","author":"D Stimac","year":"2011","unstructured":"Stimac D, et al. Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg. 2011;21:551\u2013555.","journal-title":"Obes Surg"},{"key":"4178_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03345708","volume":"32","author":"F Donadio","year":"2009","unstructured":"Donadio F, et al. Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients. J Endocrinol Invest. 2009;32:165\u2013168.","journal-title":"J Endocrinol Invest"},{"key":"4178_CR52","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/s11695-008-9487-x","volume":"18","author":"G Ricci","year":"2008","unstructured":"Ricci G, et al. Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients. Obes Surg. 2008;18:1438\u20131442.","journal-title":"Obes Surg"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4178-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4178-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T10:34:39Z","timestamp":1589711679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4178-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4178-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]},"assertion":[{"value":"6 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Christopher Thompson: Consultancy fees from Apollo, USGI, Olympus, Fractyl, ValenTX, Boston Scientific, Covidien; stock ownership in GI Windows; Medical Advisory Board member, Fractyl. Violeta Popov, Nitin Kumar, Maria Ciarleglio, Yanhong Deng and Loren Laine that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}